Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy

被引：0
作者：
Yoshiaki Nakamura
Takeharu Yamanaka
Keisho Chin
Haruhiko Cho
Hitoshi Katai
Masanori Terashima
Kazunari Misawa
Motohiro Hirao
Kazuhiro Yoshida
Eiji Oki
Mitsuru Sasako
Yasunori Emi
Hideaki Bando
Yoshiyuki Kawashima
Tetsu Fukunaga
Masahiro Gotoh
Takako Ishibashi
Kohei Shitara
机构：
[1] National Cancer Center Hospital East,Department of Gastroenterology and Gastrointestinal Oncology
[2] Yokohama City University,Department of Biostatistics
[3] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology
[4] Kanagawa Cancer Center,Department of Gastrointestinal Surgery
[5] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Surgery
[6] National Cancer Center Hospital,Division of Gastric Surgery
[7] Shizuoka Cancer Center,Division of Gastric Surgery
[8] Aichi Cancer Center Hospital,Department of Gastroenterological Surgery
[9] National Hospital Organization Osaka National Hospital,Department of Surgery
[10] Gifu University,Department of Surgical Oncology, Graduate School of Medicine
[11] Kyushu University Hospital,Department of Surgery and Science, Graduate School of Medical Sciences
[12] Hyogo College of Medicine,Department of Surgery
[13] Saiseikai Fukuoka General Hospital,Department of Surgery
[14] Saitama Cancer Center,Department of Gastroenterological Surgery
[15] St. Marianna University School of Medicine,Department of Gastroenterological and General Surgery
[16] Osaka Medical College,Cancer Chemotherapy Center
[17] Yokohama City University Hospital,Center for Novel and Exploratory Clinical Trials
来源：
Annals of Surgical Oncology | 2019年 / 26卷
关键词：
Capecitabine Plus Oxaliplatin (CAPOX); Survival Outcomes; Gastric Cancer; pStage; Histological Type;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：465 / 472
页数：7
相关论文
共 50 条
[41]   Protocol digest of a phase III trial to evaluate the efficacy of preoperative chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with postoperative S-1 in locally advanced gastric cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA Trial) [J].
Mizusawa, Junki ;
Tokunaga, Masanori ;
Machida, Nozomu ;
Yabusaki, Hiroshi ;
Kawabata, Ryohei ;
Imamura, Hiroshi ;
Kinoshita, Takahiro ;
Nomura, Takashi ;
Nunobe, Souya ;
Tsuji, Kunihiro ;
Katayama, Hiroshi ;
Fukuda, Haruhiko ;
Boku, Narikazu ;
Yoshikawa, Takaki ;
Terashima, Masanori .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (02) :168-173
[42]   Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy [J].
Feng, Daofu ;
Leong, Meiha ;
Li, Ting ;
Chen, Lin ;
Li, Tao .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
[43]   Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy [J].
Daofu Feng ;
Meiha Leong ;
Ting Li ;
Lin Chen ;
Tao Li .
World Journal of Surgical Oncology, 13
[44]   Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy [J].
Toru Aoyama ;
Takaki Yoshikawa ;
Tsutomu Hayashi ;
Hiroshi Kuwabara ;
Yo Mikayama ;
Takashi Ogata ;
Haruhiko Cho ;
Akira Tsuburaya .
Annals of Surgical Oncology, 2012, 19 :1568-1574
[45]   Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial [J].
Zhichao Jiang ;
Yibin Xie ;
Wen Zhang ;
Chunxia Du ;
Yuxin Zhong ;
Yuelu Zhu ;
Liming Jiang ;
Lizhou Dou ;
Kang Shao ;
Yongkun Sun ;
Qi Xue ;
Yantao Tian ;
Shugeng Gao ;
Dongbing Zhao ;
Aiping Zhou .
Gastric Cancer, 2024, 27 :571-579
[46]   Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial [J].
Jiang, Zhichao ;
Xie, Yibin ;
Zhang, Wen ;
Du, Chunxia ;
Zhong, Yuxin ;
Zhu, Yuelu ;
Jiang, Liming ;
Dou, Lizhou ;
Shao, Kang ;
Sun, Yongkun ;
Xue, Qi ;
Tian, Yantao ;
Gao, Shugeng ;
Zhao, Dongbing ;
Zhou, Aiping .
GASTRIC CANCER, 2024, 27 (03) :571-579
[47]   Adjuvant Chemotherapy with S-1 plus Cisplatin for Patients with Stage III Gastric Cancer After Curative Resection [J].
Mita, Kazuhito ;
Ito, Hideto ;
Ota, Emi ;
Takahashi, Koudai ;
Hashimoto, Masatoshi ;
Asakawa, Hideki ;
Hayashi, Takashi ;
Fujino, Keiichi .
ANTICANCER RESEARCH, 2017, 37 (03) :1329-1333
[48]   Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer [J].
Takahari, D. ;
Hamaguchi, T. ;
Yoshimura, K. ;
Katai, H. ;
Ito, S. ;
Fuse, N. ;
Kinoshita, T. ;
Yasui, H. ;
Terashima, M. ;
Goto, M. ;
Tanigawa, N. ;
Shirao, K. ;
Sano, T. ;
Sasako, M. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) :1423-1428
[49]   Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer [J].
D. Takahari ;
T. Hamaguchi ;
K. Yoshimura ;
H. Katai ;
S. Ito ;
N. Fuse ;
T. Kinoshita ;
H. Yasui ;
M. Terashima ;
M. Goto ;
N. Tanigawa ;
K. Shirao ;
T. Sano ;
M. Sasako .
Cancer Chemotherapy and Pharmacology, 2011, 67 :1423-1428
[50]   Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer [J].
Yoshikawa, Takaki ;
Morita, Satoshi ;
Tanabe, Kazuaki ;
Nishikawa, Kazuhiro ;
Ito, Yuichi ;
Matsui, Takanori ;
Fujitani, Kazumasa ;
Kimura, Yutaka ;
Fujita, Junya ;
Aoyama, Toru ;
Hayashi, Tsutomu ;
Cho, Haruhiko ;
Tsuburaya, Akira ;
Miyashita, Yumi ;
Sakamoto, Junichi .
EUROPEAN JOURNAL OF CANCER, 2016, 62 :103-111
12345